This is the authors' abstract. We don't add key points for this paper.
Circulating eotaxin and eotaxin mRNA levels in visceral adipose tissue were increased in obesity in mice and humans. Adipose tissue explants secrete eotaxin, and the stromal/vascular component of adipose tissue seems to be the predominant source of eotaxin. Diet-induced weight loss in humans led to reduction in plasma eotaxin levels, demonstrating that clinical interventions that target obesity can modulate systemic eotaxin levels.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Vasudevan et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: